Novavax (NVAX) has recently been on Zacks.com's list of the most searched stocks. Therefore, you might want to consider some of the key factors that could influence the stock's performance in the near ...

Check the time stamp on this data. Updated AI-Generated Signals for Novavax Inc. (NVAX) available here: NVAX.

On Monday, Novavax Inc (NVAX) stock saw a decline, ending the day at $12.8 which represents a decrease of $-0.11 or -0.85% from the prior close of $12.91. The stock opened at $13.01 and touched a low ...

The latest trading session saw Novavax (NVAX) ending at $12.80, denoting a -0.85% adjustment from its last day's close. The stock trailed the S&P 500, which registered a daily gain of 0.28%. Meanwhile ...

Though Novavax is behind in the COVID-19 vaccine race, a blockbuster deal with Sanofi and a differentiated product means the ...

Novavax Inc. closed $10.57 below its 52-week high ($23.86), which the company reached on June 6th.

Shares of Novavax Inc. NVAX slid 9.41% to $12.04 Wednesday, on what proved to be an all-around mixed trading session for the stock market, with the NASDAQ Composite Index COMP rising 0.04% to ...

Buying $1000 In NVAX: If an investor had bought $1000 of NVAX stock 5 years ago, it would be worth $2,000.00 today based on a ...

Novavax, Inc. (Nasdaq: NVAX), a global company advancing protein-based vaccines with its Matrix-M™ adjuvant, today announced ...

Buy NVAX slightly over 12.96 target 18.31 stop loss @ 12.92 Short NVAX slightly under 18.31, target 12.96, stop loss @ 18.36 ...

As of 16 September at 11:00 am GMT-4. Market open. Adjusted closing price adjusted for splits and dividend and/or capital gain distributions.

As of 13 September at 3:37 pm GMT-4. Market open. Adjusted closing price adjusted for splits and dividend and/or capital gain distributions.